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Abstract
Tc-99m sulesomab is indicated in bone and joint infection, but 
reading of scans can be affected by pre-existing conditions. This 
case report describes a case of Klippel-Trenaunay syndrome 
(KTS) which results in vascular malformations of one or more 
limbs. Tc-99m sulesomab imaging demonstrated persistent 
blood pool activity up to 20 hours post injection. However, 
despite this, septic arthritis could be identified with confidence 
in the same limb.
Key words: Klippel-Trenaunay syndrome, Tc-99m sulesomab 
Nuclear Med Rev 2010; 13, 2: 84–86
Introduction
In 1900, the French physicians Klippel and Trenaunay de-
scribed a rare syndrome: Klippel-Trenaunay syndrome (KTS) [1]. 
The syndrome is an autosomal-dominant disorder characterized 
by a triad of cutaneous vascular nevi, soft tissue, or bony hyper-
trophy, and varicose veins or venous malformations involving one 
or more extremities and often associated with chylous ascites [2]. 
Currently, Klippel-Trenaunay syndrome can be diagnosed on the 
basis of any two of these three features [3].
We report a case of extensive left leg KTS with minimal 
symptoms and its affect on imaging with Tc-99m sulesomab for 
septic arthritis.
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Case report 
A 51-year-old woman was referred to our institution for 
a three-phase bone scan of the left knee joint to exclude post 
arthroscopic joint infection. She was a known case of Klippel-Tre-
naunay syndrome for five years but had with symptoms except 
in her of left knee in which she suffered a lateral meniscal tear. 
She had a low-flow venous malformation along the whole length 
of the left thigh, calf, and short saphenous vein on duplex ultra-
sound imaging. Several small varicose veins were present in both 
the postero and lateral aspect of the left thigh extending to the 
calf and foot. She had no limb deformity or gigantism, and no 
true birthmarks on either leg or buttock. MRI of the left knee joint 
showed innumerable abnormal vessels throughout the region of 
the knee in an intra- and extra-articular distribution suggesting 
arterio-venous malformation. 
She had a history of intermittent pain, swelling, and locking of 
the left knee over 5 years and her venous malformation was stable. 
She was advised to use graduated compression stockings but she 
continued to suffer locking and pain in that knee. To reduce her 
symptoms she underwent an arthroscopy. Debridement of the de-
generative meniscal tear was performed and generalized arthritic 
changes were also noted. After this procedure she developed pain, 
swelling of the joint, and pyrexia. On physical examination the left 
knee was swollen and bruised but was not noted to be warmer to 
the touch than the right knee.
She was referred to our department for a three-phase bone 
scan to identify if septic arthritis of the left knee was a possibil-
ity. Increased uptake was noted in the first two phases of the 
Tc-99m MDP scintigraphy involving the whole left knee, and in the 
three-hour static phase there was increased uptake seen in the 
medial aspect of the tibia corresponding to the osteolytic lesion 
in the margin of medial tibial plateau seen on X-ray (Figures 1–3). 
These findings suggested that the joint could indeed be infected 
and a confirmatory Tc-99m sulesomab scan was arranged. Local 
images of the knee were performed 1 and 5 hours after injection 
of 793 MBq of Tc-99m sulesomab. Both sets of images showed 
diffusely increased activity in the left leg compared to the right 
(Figure 4). However, in addition there were small areas of focal 
uptake throughout the leg seen above and below the knee. These 
changes were attributed to the patient’s KTS.
In addition to these abnormalities there was increasing focal 
accumulation of Tc-99m sulesomab around the left knee joint 
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consistent with a septic arthritis or severe inflammation of the left 
joint with normal activity seen in the right knee. 
Discussion
Klippel-Trenaunay syndrome (KTS) is a rare congenital 
malformation characterised by the triad of capillary malforma-
tions (port-wine stains), varicose veins, and hypertrophy of the soft 
tissues and bones [4, 5]. The absence of arteriovenous shunting 
differentiates this entity from other congenital vascular malforma-
tions of venous predominance such as Parker-Weber syndrome 
[6]. The diagnosis is confirmed by the presence of at least two 
of the three clinical features, although most patients will have all 
three manifestations [1, 3, 7, 8].
The aetiology of KTS remains unknown although it is thought to 
be a mesodermal defect that leads to an alteration in local regula-
tion or the production of growth factors affecting angiogenesis. 
This vascular overgrowth is responsible for the increase in blood 
flow, producing hyperthermia and anomalous growth patterns [9]
and the increased flow seen on both Tc-99m MDP and Tc-99m 
sulesomab imaging.
The exact prevalence of this syndrome is unknown. It is esti-
mated that there are 900 affected individuals worldwide, but many 
cases may be unrecognised or unreported [10]. Most cases of 
KTS are sporadic and diagnosed at birth or early childhood, with 
males and females being affected equally. There is no known racial 
predilection found in KTS [3].
Hypertrophy is the most variable of the three classic fea-
tures of KTS [3], although up to 30% of patients do not present with 
hypertrophy [11]. Enlargement of the extremity consists of bone 
elongation, circumferential soft tissue hypertrophy, or both [3, 12, 
13]. The lower limb, upper limb, or both are affected in 95%, 5%, 
and 15% of cases with KTS, respectively; however, the majority 
of cases display unilateral changes [14]. Most series describe 
hypertrophy of tissue/bones in the involved limb [3, 6, 15], but 
our patient showed no evidence of limb deformity or gigantism, 
or true birthmarks on either leg. There were, however, osteolytic 
lesions in the margin of medial tibial plateau on X-ray, and tropic 
changes were observed secondary to venous stasis as reported 
by Servelle et al. [15].
Capillary malformations are the most common cutane-
ous manifestation of KTS [3]. It typically involves the enlarged 
limbs, but skin changes may be seen on other parts of the body 
[12]. Varicose veins are present in the majority of the patients with 
KTS [13]. The lower extremity varicosities tend to be more promi-
nent laterally [16]. An enlarged tortuous, superficial venous trunk 
can be identified in the affected leg laterally above the knee and 
the thigh [11, 13]. This represents the abnormal persistence of 
an embryonic lateral vein, which normally regresses at 8 weeks of 
gestation [17].
Our patient showed low-flow venous malformation along the 
whole length of the left thigh, calf, and short saphenous vein on 
duplex scan. Several small varicose veins were present in the both 
postero and lateral aspect of the left thigh extending to the calf 
and foot. Innumerable abnormal vessels coursing throughout the 
region of the knee in an intra and extra articular distribution on MRI 
suggested arteriovenous malformation.
However, despite all these vascular abnormalities, the use of 
two-phase imaging with Tc-99m sulesomab allowed identification 
Figure 3. Static Tc-99m MDP image confirming intense uptake in the 
left medial tibial plateau, suggesting infection.
Figure 1. Osteolytic lesion seen in left-sided medial tibial plateau, 
suggestive of infection.
Figure 2. Blood pool images showing intense uptake in the tissues 
surrounding the left knee.
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of the presence of infection, showing that pattern recognition and 
changing patterns of activity over time still play a significant role in 
the skills required by the nuclear medicine physician.
Conclusions
Klippel-Trenaunay syndrome is a rare condition, which can 
have a direct appearance on both the blood pool phase of the 
bone scan and Tc-99m sulesomab imaging. It is still possible, 
despite these abnormalities, to identify co-existing infection with 
the use of dual-phase Tc-99m sulesomab imaging.
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Figure 4. Five-hour Tc-99m sulesomab images showing a vascular malformation in the thigh and varicosed vein in the leg (arrowed “A”), and the 
intense uptake in the left knee due to septic arthritis (arrowed “B”).
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